CompletedNot Applicable

Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.

Egypt260 participantsStarted 2018-09-01

Plain-language summary

Our study, retrospectively evaluate the characteristics of and the risk factors for the occurrence of nocturnal enuresis in epileptic children kept on valproate monotherapy. Epileptic children with the age ranged 5 up to 15 years who were started and kept up on valproate monotherapy. In this study, a child determined to have nocturnal enuresis based on the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fourth edition: "an involuntary voiding of urine during sleep, with a severity of at least twice a week, in children aged 5 years or older, in the absence of congenital or acquired defects of the nervous system."

Who can participate

Age range5 Years – 15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Epileptic children kept up on valproate monotherapy and developed nocturnal enuresis. * Age ranged 5 up to 15 years. Exclusion Criteria: * Combined therapy with other antiepileptic drugs, * Abnormal cerebral imaging, * Poor seizure control, * Primary nocturnal enuresis (a child didn't accomplish any times of evening dryness -over a time of 6 successive months). * Congenital or acquired defects of the nervous system. * Urinary system anomalies, or * Intellectual disability.

What they're measuring

Nocturnal enuresis

Timeframe: 6 months

Trial details

NCT IDNCT04191863

SponsorMansoura University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06-01

View on ClinicalTrials.gov More Epilepsy trials